Source: Frontiers in Pharmacology. Unidade: FMRP
Subjects: CANABINOIDES, ESQUIZOFRENIA, SEROTONINA, MODELOS ANIMAIS DE DOENÇAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PERES, Fernanda Fiel et al. Cannabidiol administered during peri-adolescence prevents behavioral abnormalities in an animal model of schizophrenia. Frontiers in Pharmacology, v. 9, 2018Tradução . . Disponível em: https://doi.org/10.3389/fphar.2018.00901. Acesso em: 29 set. 2024.APA
Peres, F. F., Diana, M. C., Levin, R., Suiama, M. A., Almeida, V., Vendramini, A. M., et al. (2018). Cannabidiol administered during peri-adolescence prevents behavioral abnormalities in an animal model of schizophrenia. Frontiers in Pharmacology, 9. doi:10.3389/fphar.2018.00901NLM
Peres FF, Diana MC, Levin R, Suiama MA, Almeida V, Vendramini AM, Santos CM, Zuardi AW, Hallak JEC, Crippa JA de S, Abilio VC. Cannabidiol administered during peri-adolescence prevents behavioral abnormalities in an animal model of schizophrenia [Internet]. Frontiers in Pharmacology. 2018 ; 9[citado 2024 set. 29 ] Available from: https://doi.org/10.3389/fphar.2018.00901Vancouver
Peres FF, Diana MC, Levin R, Suiama MA, Almeida V, Vendramini AM, Santos CM, Zuardi AW, Hallak JEC, Crippa JA de S, Abilio VC. Cannabidiol administered during peri-adolescence prevents behavioral abnormalities in an animal model of schizophrenia [Internet]. Frontiers in Pharmacology. 2018 ; 9[citado 2024 set. 29 ] Available from: https://doi.org/10.3389/fphar.2018.00901